pISSN 1226-4512 eISSN 2093-3827

Article

home Article View

Original Article

Korean J Physiol Pharmacol 2021; 25(5): 439-448

Published online September 1, 2021 https://doi.org/10.4196/kjpp.2021.25.5.439

Copyright © Korean J Physiol Pharmacol.

Anti-inflammatory effects of DA-9601, an extract of Artemisia asiatica, on aceclofenac-induced acute enteritis

Ju Hwan Kim1,#, Chang Yell Shin2,#, Sun Woo Jang2, Dong-Seok Kim3, Wonae Lee4, Hyung-Gun Kim1,5, and Hak Rim Kim1,*

1Department of Pharmacology, College of Medicine, Dankook University, Cheonan 31116,2Research Institute of Dong-A ST Co., Ltd., Yongin 17073, 3Department of Biochemistry, College of Medicine, Chung-Ang University, Seoul 06974, 4Department of Pathology, College of Medicine, Dankook University, Cheonan 31116, 5 NeuroVis Inc., Cheonan 31035, Korea

Correspondence to:Hak Rim Kim
E-mail: hrkim@dankook.ac.kr

#These authors contributed equally to this work.

Received: February 26, 2021; Revised: March 16, 2021; Accepted: May 6, 2021

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright © Korean J Physiol Pharmacol, pISSN 1226-4512, eISSN 2093-3827

Abstract

DA-9601 is an extract obtained from Artemisia asiatica, which has been reported to have anti-inflammatory effects on gastrointestinal lesions; however, its possible anti-inflammatory effects on the small intestine have not been studied yet. Therefore, in this study, we investigated the protective effects of DA-9601 against the ACF-induced small intestinal inflammation. Inflammation of the small intestine was confirmed by histological studies and the changes in the CD4+ T cell fraction induced by the inflammation-related cytokines, and the inflammatory reactions were analyzed. Multifocal discrete small necrotic ulcers with intervening normal mucosa were frequently observed after treatment with ACF. The expression of IL-6 , IL-17, and TNF-α genes was increased in the ACF group; however, it was found to have been significantly decreased in the DA-9601 treated group. In addition, DA-9601 significantly decreased the levels of proinflammatory mediators such as IL-1β, GMCSF, IFN-γ, and TNF-α; the anti-inflammatory cytokine IL-10, on the other hand, was observed to have increased. It is known that inflammatory mediators related to T cell imbalance and dysfunction continuously activate the inflammatory response, causing chronic tissue damage. The fractions of IFN-γ+ Th1 cells, IL-4+ Th2 cells, IL-9+ Th9 cells, IL-17+ Th17 cells, and Foxp3+ Treg cells were significantly decreased upon DA-9601 treatment. These data suggest that the inflammatory response induced by ACF is reduced by DA-9601 via lowering of the expression of genes encoding the inflammatory cytokines and the concentration of inflammatory mediators. Furthermore, DA-9601 inhibited the acute inflammatory response mediated by T cells, resulting in an improvement in ACF-induced enteritis.

Keywords: DA-9601, Inflammation, NSAIDs, Small intestine, T cell